<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7518803\results\search\zoonosis\results.xml">
  <result pre="long-term damage, means that the overall health burden caused by" exact="SARS-CoV-2 infection" post="may be under-estimated because COVID-19 patients developed cardiovascular system"/>
  <result pre="In combination with recently published medical data of patients having" exact="SARS-CoV-2 infection" post="and the latest studies, the manifestations of damage to"/>
  <result pre="Organization (WHO) declared that the novel coronavirus infection was named" exact="coronavirus disease 2019" post="(COVID-19) [1]. By March 11, 2020, more than 118,000"/>
  <result pre="also suffer from severe heart failure in the wake of" exact="SARS-CoV-2 infection" post="and eventually die of sudden cardiac death [7]. Likewise,"/>
  <result pre="may have a long-term effect on the heart [17,18]. 2.3" exact="SARS-CoV-2 infection" post="with underlying cardiovascular disease Some SARS-CoV-2 patients have chronic"/>
  <result pre="severe hypertension and cardiac insufficiency. Further analysis showed that the" exact="SARS-CoV-2 infection" post="only induced heart failure and systemic multiorgan dysfunction in"/>
  <result pre="cause stress cardiomyopathy. 4 Treatment of cardiovascular injury associated with" exact="SARS-CoV-2 infection" post="4.1 Antiviral therapy The Diagnosis and Treatment Plan of"/>
  <result pre="4.2 ACE2 as a potential target during the treatment of" exact="SARS-CoV-2 infection" post="SARS-CoV-2 mainly invades alveolar epithelial cells via ACE2 and"/>
  <result pre="ACE2 can be regarded as a potential therapeutic target for" exact="SARS-CoV-2 infection." post="These possibilities include blocking the binding between ACE2 and"/>
  <result pre="4.2.2 ACE inhibitors (ACEIs) SARS-related studies have shown that after" exact="SARS-CoV infection," post="ACE2 was downregulated in the lungs, causing ACE/ACE2 imbalance."/>
  <result pre="evidence that ACEIs and ARBs can increase the risk of" exact="SARS-CoV-2 infection" post="or cause deterioration of COVID-19 patients [62], so ACEIs"/>
  <result pre="and kidneys [65]. 4.3 Treatment of cytokine storms associated with" exact="SARS-CoV-2 infection" post="As mentioned previously, SARS-CoV-2 infection could induce overactivation of"/>
  <result pre="of cytokine storms associated with SARS-CoV-2 infection As mentioned previously," exact="SARS-CoV-2 infection" post="could induce overactivation of the immune system, resulting in"/>
  <result pre="and protecting organ function is a promising approach to treat" exact="SARS-CoV-2 infection" post="and reduce mortality. Currently, most targeted drugs for COVID-19"/>
  <result pre="(mAbs) may be used to treat cytokine storms associated with" exact="SARS-CoV-2 infection" post="[68]. Zhou et al. found that granulocyte-macrophage colony stimulating"/>
  <result pre="main methods for treating and preventing COVID-19. 4.4 Treatment of" exact="SARS-CoV-2 infection" post="with underlying cardiovascular diseases Current data show that all"/>
  <result pre="data show that all age groups are at risk of" exact="SARS-CoV-2 infection," post="and the condition is generally more severe in elderly"/>
  <result pre="improve the prognosis of patients. 6 Conclusion The outbreak of" exact="SARS-CoV-2 infection" post="has been defined as a pandemic that is seriously"/>
  <result pre="Wuhan, ChinaLancet395202049750631986264 7ChenN.ZhouM.DongX.QuJ.GongF.HanY.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet (London, England)3952020507513 8WangD.HuB.HuC.ZhuF.LiuX.ZhangJ.Clinical"/>
  <result pre="of cardiovascular magnetic resonance imaging in patients recently recovered from" exact="coronavirus disease 2019" post="(COVID-19)JAMA Cardiol.2020E1E9 19Vital surveillances: the epidemiological characteristics of an"/>
  <result pre="injury signs are associated with higher and earlier mortality in" exact="coronavirus disease 2019" post="(COVID-19)medRxiv202010.1101/2020.02.26.20028589(2020.2002.2026.20028589) 37van der PollT.LeviM.Crosstalk between inflammation and coagulation: the"/>
  <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP)medRxiv202010.1101/2020.02.10.20021832(2020.2002.2010.20021832) 69ZhouY.FuB.ZhengX.WangD.ZhaoC.qiY.Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+"/>
 </snippets>
</snippetsTree>
